DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19

IndiaTimes

06 Oct 2020 0 shares 1 views

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19

IndiaTimes

Published 06 Oct 2020

The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for Covid-19, ICMR officials said on Tuesday.

Full Article

NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...

Proactive Investors 30 Oct 2020

Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..

NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors 30 Oct 2020
Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India
IndiaTimes 17 Oct 2020
Dr Reddy's gets DCGI nod for trial of Covid vaccine Sputnik V in India
IndiaTimes 17 Oct 2020
AIM ImmunoTech is developing immuno-therapeutics to treat multiple types of cancers and fighting coronavirus too
Proactive Investors 13 Oct 2020

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19

You might like

Related news coverage

NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...

Advertisement